Guidelines support telemedicine as an effective tool for allergists
A new position paper in Annals of Allergy, Asthma and Immunology, the scientific publication of the American College of Allergy, Asthma and Immunology (ACAAI), recognizes that allergy is one of the top conditions patients seek care for using telemedicine. ACAAI supports the use of telemedicine for allergy patients and hopes the new guidelines encourage more allergists to use the technology in their practices.
Telemedicine can expand access to care. According to a 2015 study, the mean no-show rate for physician appointments was upwards of 20%, with a mean cost per patient of approximately $200. Telemedicine technologies can connect patients with the clinician without having to incur long travel times and associated expenses, particularly if they do not have ready access or are unwilling to travel. According to the American Telemedicine Association, more than 15 million Americans received some form of medical care remotely in 2015, with a projected increase to 158.4 million by 2020.
Telemedicine use for allergy care is likely to expand with broader telehealth applications in medicine, although further research into effect and outcomes is needed. Many allergists now do initial visits by telemedicine to help determine if in-office testing is required. For certain types of follow-up visits, such as a check up on how a medication or allergen immunotherapy is doing, telemedicine can save time and money.
The optimistic conclusion of the position paper states, “The ACAAI will monitor this rapidly changing landscape to ensure provision of high-quality care to the patient with allergic and immunologic disorders and consistency of practice in an era of futuristic technologies. Despite the challenges, the current and future benefits of telemedicine are promising and exciting for allergists, patients, and healthcare systems.”
